Elsevier Inc.

SHERPA: Unknown

People

  1. Kris
    Kris
  2. Riely
    Riely
  3. Drilon
    Drilon
  4. Chaft
    Chaft
  5. Rusch
    Rusch
  6. Ladanyi
    Ladanyi
  7. Rudin
    Rudin
  8. Zauderer
    Zauderer
  9. Wu
    Wu
  10. Offin
    Offin

Groups

  1. Department of Medicine (201)
  2. Solid Tumor Oncology Division (201)
  3. Thoracic Oncology (201)
  4. GSK Faculty (66)
  5. Surgery (48)
  6. Human Oncology and Pathogenesis Program (37)
  7. Tow Center for Developmental Oncology (TCDO) (36)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (35)
  9. Epidemiology and Biostatistics (33)
  10. Radiation Oncology, Department of (33)
Search Within
  1. "Thoracic Oncology"
  2. "Journal article"
Formats
  1. Journal Article (201)
Groups
  1. Department of Medicine (201)
  2. Solid Tumor Oncology Division (201)
  3. Thoracic Oncology (201)
  4. GSK Faculty (66)
  5. Surgery (48)
  6. Human Oncology and Pathogenesis Program (37)

More Groups

People
  1. Mark Kris (77)
  2. Gregory Riely (52)
  3. Marc Ladanyi (34)
  4. Charles Rudin (32)
  5. Alexander Drilon (29)
  6. Andreas Rimner (29)

More People

Years
  1. 2024 (6)
  2. 2023 (15)
  3. 2022 (19)
  4. 2021 (13)
  5. 2020 (13)
  6. 2019 (15)

More Years

Publications
  1. Journal of Thoracic Oncology (120)
  2. Clinical Lung Cancer (19)
  3. Seminars in Oncology (13)
  4. International Journal of Radiation Oncology, Biology, Physics (10)
  5. Radiotherapy and Oncology (7)
  6. European Journal of Cancer (6)

More Publications

Results (201)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Brief report: Updated efficacy and safety data from an integrated analysis of entrectinib in locally advanced/metastatic ROS1 fusion-positive non–small-cell lung cancer
    Journal Article

    Fan, Y.; Drilon, A.; Chiu, C. H.; Loong, H. H. F.; Siena, S.; Krzakowski, M.; Dziadziuszko, R.; Zeuner, H.; Xue, C.; Krebs, M. G.
    Clinical Lung Cancer (2024)

    Fulltext@MSK | Save
  • Microsatellite instability and mismatch repair deficiency define a distinct subset of lung cancers characterized by smoking exposure, high tumor mutational burden, and recurrent somatic MLH1 inactivation
    Journal Article

    Yang, S. R.; Gedvilaite, E.; Ptashkin, R.; Chang, J.; Ziegler, J.; Mata, D. A.; Villafania, L. B.; Nafa, K.; Hechtman, J. F.; Benayed, R.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • A brief report on the patterns of mediastinal nodal failure in resectable stage IB-IIIA NSCLC treated with neoadjuvant immunotherapy combinations, a secondary analysis of a prospective trial
    Journal Article

    Mao, S.; Rosner, S.; Forde, P. M.; Chaft, J. E.; Jones, D. R.; Spicer, J.; Hales, R. K.; Ha, J. S.; Hu, C.; Voong, K. R.
    Clinical Lung Cancer (2024)

    Fulltext@MSK | Save
  • Clinical outcomes of stereotactic body radiation therapy for malignant pleural mesothelioma
    Journal Article

    Shin, J. Y.; Offin, M.; Simone, C. B. 2nd; Zhang, Z.; Shepherd, A. F.; Wu, A. J.; Shaverdian, N.; Gelblum, D. Y.; Gomez, D. R.; Sauter, J. L.; more...
    Radiotherapy and Oncology (2024)

    Fulltext@MSK | Save
  • Brief report: Tyrosine kinase inhibitors for lung cancers that inhibit MATE-1 can lead to “false” decreases in renal function
    Journal Article

    Chen, M. F.; Harada, G.; Liu, D.; DeMatteo, R.; Falcon, C.; Wilhelm, C.; Kris, M. G.; Drilon, A.; Gutgarts, V.
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation
    Journal Article

    Thor, M.; Fitzgerald, K.; Apte, A.; Hun Oh, J.; Iyer, A.; Odiase, O.; Nadeem, S.; Yorke, E. D.; Chaft, J.; Wu, A. J.; more...
    Radiotherapy and Oncology (2024)

    Fulltext@MSK | Save
  • Impact of aneuploidy and chromosome 9p loss on tumor immune microenvironment and immune checkpoint inhibitor efficacy in NSCLC
    Journal Article

    Alessi, J. V.; Wang, X.; Elkrief, A.; Ricciuti, B.; Li, Y. Y.; Gupta, H.; Spurr, L. F.; Rizvi, H.; Luo, J.; Pecci, F.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • International Association for the Study of Lung Cancer Study of reproducibility in assessment of pathologic response in resected lung cancers after neoadjuvant therapy
    Journal Article

    Dacic, S.; Travis, W.; Redman, M.; Saqi, A.; Cooper, W. A.; Borczuk, A.; Chung, J. H.; Glass, C.; Lopez, J. M.; Roden, A. C.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Short report of a phase ii trial of nintedanib in recurrent malignant pleural mesothelioma (MPM)
    Journal Article

    Wozniak, A. J.; Schneider, B.; Kalemkerian, G. P.; Daly, B.; Chen, W.; Ventimiglia, J.; Nagasaka, M.; Zauderer, M. G.
    Clinical Lung Cancer (2023)

    Fulltext@MSK | Save
  • Combination therapy with MDM2 and MEK inhibitors is effective in patient-derived models of lung adenocarcinoma with concurrent oncogenic drivers and MDM2 amplification
    Journal Article

    Elkrief, A.; Odintsov, I.; Markov, V.; Caeser, R.; Sobczuk, P.; Tischfield, S. E.; Bhanot, U.; Vanderbilt, C. M.; Cheng, E. H.; Drilon, A.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save